Debut Plus

₹3,528.4

▼ -89.73 -2.48%

As of 23 Oct 2026 · delayed

NSE Listed

Kwality Pharmaceuticals Limited (KPL)

Volume: 38,716Avg Vol 1W: 34,793Avg Vol 1M: 28,952.0552W Range:₹1,561₹3,949
NSE BSE www.kwalitypharma.com AI Report
Key Ratios
Checked 17h ago
Market Cap₹3,661 Cr
Current Price₹3,528.4
Previous Close₹3,618.13
High / Low (52w)₹3,949 / ₹1,561
Volume38,716
Avg Vol (1W)34,793
Avg Vol (1M)28,952.05
Stock P/E44.84
Book Value₹318.8
Dividend Yield0%
ROE20.31%
ROA13.69%
Revenue (TTM)₹506 Cr
Revenue Growth—
Profit Margin14.63%
Total Debt—
Shares Outstanding1 Cr
Face Value₹10
EPS (TTM)₹78.68
P/B11.08
Debt / Equity0.41
50 DMA₹3,499.48
200 DMA₹2,758.07
Day change-2.48%
Price Chart
₹3,528.4▲ 112.22% · 1Y
₹3845₹15805.7L
2026-04-20
2026-10-23

20-day avg volume: 29K shares

Pros
  • Healthy return on equity of 20.3%.
  • Company is almost debt-free.
  • Revenue grew 17% YoY.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹90 Cr₹84 Cr₹116 Cr₹111 Cr₹111 Cr₹123 Cr₹157 Cr₹162 Cr
EBITDA₹15 Cr₹14 Cr₹22 Cr₹20 Cr₹21 Cr₹26 Cr₹35 Cr₹37 Cr
Net Profit₹8 Cr₹9 Cr₹14 Cr₹12 Cr₹14 Cr₹16 Cr₹25 Cr₹26 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026Jun 2026
Revenue₹116 Cr₹372 Cr₹111 Cr₹111 Cr₹123 Cr₹157 Cr₹506 Cr₹162 Cr
EBITDA₹22 Cr₹64 Cr₹20 Cr₹21 Cr₹26 Cr₹35 Cr₹101 Cr₹37 Cr
Net Profit₹15 Cr₹40 Cr₹12 Cr₹14 Cr₹16 Cr₹25 Cr₹67 Cr₹26 Cr
EPS—38.36————64.9—
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹105 Cr₹133 Cr₹166 Cr₹341 Cr₹354 Cr₹394 Cr₹447 Cr₹592 Cr
Total Liabilities₹69 Cr₹88 Cr₹106 Cr₹161 Cr₹155 Cr₹172 Cr₹185 Cr₹262 Cr
Equity₹36 Cr₹45 Cr₹60 Cr₹180 Cr₹199 Cr₹223 Cr₹262 Cr₹330 Cr
Total Debt————————
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹17 Cr₹9 Cr₹33 Cr₹102 Cr₹48 Cr₹44 Cr₹69 Cr₹38 Cr
Investing₹-12 Cr₹-18 Cr₹-23 Cr₹-63 Cr₹-48 Cr₹-26 Cr₹-29 Cr₹-35 Cr
Financing₹-2 Cr₹12 Cr₹1 Cr₹6 Cr₹1 Cr₹-17 Cr₹-14 Cr₹7 Cr
Free Cash Flow₹17 Cr₹9 Cr₹33 Cr₹102 Cr₹48 Cr₹44 Cr₹69 Cr₹38 Cr
Shareholding
Promoter 54.86% Institutions 2.5% Public 42.64%
Efficiency & Working Capital
ROCE21.5%
Interest Coverage9.2
Dividend Payout—
Debtor Days203 d
Inventory Days57 d
Payable Days74 d
Cash Conversion Cycle186 d
Working Capital Days260 d
Shareholding Details

As of 2026-09-30

Promoter54.9%
FII2.5%
DII0%
Institutions2.5%
Public42.6%
Promoter Pledge0%
No. of Shareholders17,880
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodDec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Promoters54.8%54.8%54.8%54.8%54.8%54.8%54.8%54.8%54.8%54.9%54.9%54.9%
FIIs0%0%0%0%0%0%0%0%0.5%2.8%3.1%2.5%
DIIs0%0%0%0%0%0.3%0.3%0.3%0.3%0.4%0.6%0%
Public45.2%45.2%45.2%45.2%45.1%44.9%44.8%44.8%44.3%42%41.4%42.6%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders5,7865,6955,2737,4878,9479,42010,11511,59510,70910,55513,27917,880
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Ramesh AroraShareholding of Promoter and Promoter Group26%27,00,632
Ajay AroraShareholding of Promoter and Promoter Group13.6%14,11,579
Aditya AroraShareholding of Promoter and Promoter Group12%12,41,039
Deepak BansalPublic Shareholding8.2%8,46,525
Manohar DevabhaktuniPublic Shareholding5%5,16,735
Kadayam Ramnathan BharatPublic Shareholding2%2,05,000
Ark Global Emerging Companies, LpPublic Shareholding1.8%1,90,518
Jani Bhasha ShaikPublic Shareholding1.5%1,50,000
Dheeraj Kumar LohiaPublic Shareholding1.4%1,42,447
Anju AroraShareholding of Promoter and Promoter Group1.3%1,35,634
Onkar SinghPublic Shareholding1.1%1,13,200
Geeta AroraShareholding of Promoter and Promoter Group1.1%1,11,500
Jugal Kishore HufShareholding of Promoter and Promoter Group0.9%92,350
Aarti BajajShareholding of Promoter and Promoter Group0%144
Sachin SethShareholding of Promoter and Promoter Group0%10
Board of Directors
NameDesignationYear
Ramesh KumarExecutive Director & MD2026
Ajay AroraE D & Wholetime Director2026
Aditya AroraExecutive Director / Whole Time Director / CFO2026
Geeta AroraE D & Wholetime Director2026
Anju AroraE D & Wholetime Director2026
Prashanth VellankiIndependent Non Exe. Director2026
Vinod Kumar SharmaIndependent Non Exe. Director2026
Bhavesh MahajanIndependent Non Exe. Director2026
PreetMohinder Singh BediIndependent Non Exe. Director2026
Swanith KapoorIndependent Non Exe. Director2026
Gurpreet KaurCompany Sec. & Compli. Officer2026
Segments — Product
SegmentRevenueShare
Pharmaceuticals₹0 Cr—
Segments — Geography
RegionRevenueShare
Export₹195 Cr52.8%
Domestic₹175 Cr47.2%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹10161010
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-10Board Meetings—
forthcoming—Book ClosureAGM
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
20265003412
20265003412
20265003412
Insider / Designated-Person Trades

4 recent disclosure(s)

Aastha SethAcquisition · 1,000
RAMESH KUMARAcquisition · 1,948
AJAY KUMAR ARORAAcquisition · 941
ADITYA ARORAAcquisition · 948
Substantial Acquisitions (SAST)

6 disclosure(s)

Market16/02/2024 · 1,200
Market15/02/2024 · 4,919
Market30/06/2023 · 1,04,000
-27/06/2023 · 5,18,810
Market24/05/2023 - 08/06/2023 · 3,02,000
NULL15/12/2021 · 25,620
Company Information
Incorporated1983
AuditorVijay Mehra & Co
Investor Email[email protected]
🌐 www.kwalitypharma.com ↗

📍 Village Nagkalan, Majitha Road, Amritsar, Punjab, 143601

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Kotyark Industries Ltd.Kovai Medical Center & Hospital Ltd.KP Energy LimitedKPI Green Energy LimitedKalpataru Projects International Ltd.KPIT TechnologiesK P R Mill Ltd.KRBL LimitedKrebs Biochemicals & Industries Ltd.Kridhan Infra LimitedKrishana Phoschem LimitedKrishca Strapping Solutions Ltd.All “K” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search